End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
15.08 CNY | +2.65% | +2.17% | -0.40% |
Apr. 17 | Aodong Medicine's 2023 Profit Declines 18%; Revenue Up 20% | MT |
Apr. 16 | Jilin Aodong Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Business Summary
- sale of pharmaceutical products (89.4%);
- sale of food products (6.8%);
- other (3.8%).
All sales are in China.
Number of employees: 5,646
Sales per Business
CNY in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Medicine
76.6
%
| 2,150 | 74.9 % | 2,643 | 76.6 % | +22.97% |
Food
11.2
%
| 377 | 13.1 % | 386 | 11.2 % | +2.50% |
Wholesale and Retail of Chain Drug Stores
10.9
%
| 450 | 15.7 % | 377 | 10.9 % | -16.17% |
Other
7.8
%
| 202 | 7.0 % | 268 | 7.8 % | +32.57% |
Inter-segment Elimination
-6.6
%
| -312 | -10.9 % | -227 | -6.6 % | -27.21% |
Group Investment
0.1
%
| 2 | 0.1 % | 2 | 0.1 % | -7.40% |
Sales per region
CNY in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
China
100.0
%
| 2,868 | 100.0 % | 3,449 | 100.0 % | +20.26% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Shu Qin Guo
CEO | Chief Executive Officer | 61 | 97-12-31 |
Kai Yang
DFI | Director of Finance/CFO | 47 | 04-04-30 |
Da Long Zhao
DFI | Director of Finance/CFO | 50 | 99-06-30 |
Shu Yuan Zhang
DFI | Director of Finance/CFO | 52 | 07-06-17 |
Yong Feng Chen
CHM | Chairman | 57 | 00-09-30 |
Ming Jing Zhang
BRD | Director/Board Member | 42 | 17-06-30 |
Zhen Yu Wang
BRD | Director/Board Member | 43 | 04-06-30 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Xiu Lin Li
CHM | Chairman | 71 | 93-01-31 |
Shu Qin Guo
CEO | Chief Executive Officer | 61 | 97-12-31 |
Yong Feng Chen
CHM | Chairman | 57 | 00-09-30 |
Gang Xiu
BRD | Director/Board Member | 58 | 06-01-31 |
Peng Li
BRD | Director/Board Member | 42 | 20-07-16 |
Da Long Zhao
BRD | Director/Board Member | 50 | 15-12-31 |
Kai Yang
DFI | Director of Finance/CFO | 47 | 04-04-30 |
Ming Jing Zhang
BRD | Director/Board Member | 42 | 17-06-30 |
An Ning Li
BRD | Director/Board Member | 38 | 22-01-03 |
Wei Wei Xiao
BRD | Director/Board Member | 44 | 20-09-08 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 1,241,069,418 | 856,984,673 ( 69.05 %) | 45,174,031 ( 3.640 %) | 69.05 % |
Holdings
Name | Equities | % | Valuation |
---|---|---|---|
GF SECURITIES CO., LTD. 15.06% | 256,290,400 | 15.06% | 264,919,698 $ |
91,500,376 | 5.98% | 128,500,383 $ | |
36,138,251 | 3.12% | 72,302,160 $ |
Company contact information
Jilin Aodong Pharmaceutical Group Co., Ltd.
2158 Aodong Street Dunhua
133700, Yanbian Korean Autonomous Prefecture
+
http://www.jlaod.comSector
Sales per Business
Sales per region
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-0.40% | 2.49B | |
+25.83% | 661B | |
+27.00% | 566B | |
-6.76% | 352B | |
+20.34% | 332B | |
+3.00% | 283B | |
+13.09% | 231B | |
+5.46% | 200B | |
-9.61% | 195B | |
-6.26% | 145B |
- Stock Market
- Equities
- 000623 Stock
- Company Jilin Aodong Pharmaceutical Group Co., Ltd.